NASDAQ$GNTLF

Genetic Technologies Ltd · Q2 2021 earnings

Q2 2021 earnings · · Investor relations

Headline financials

Total Revenue

$12.6K

Previous: $412.14+2958.3%
EPS (adj)

-$0.98

Previous: -$1.68+41.7%
Net Income

-$3.48M

Previous: -$2.65M-31.2%
Operating Income

-$4.45M

Previous: -$3.09M-43.9%
Gross Profit

-$270K

Previous: -$206K-31.1%
R&D Expense

$1.06M

Previous: $1.13M-5.9%

Revenue & EPS history

Genetic Technologies · Revenue · Quarterly

$12.6K

Q2 2021+2,958.3%vs Q2 2020
Beat estimate in 1 of 2 quarters(50%)
ActualEstimate

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q2 2021

Historical avgQ2 2021

+3.6%

Avg return

Earnings day

-1.0%

Avg return

5 days after

+286.8%

Avg return

30 days after

68%

23 / 34 earnings

Positive

+23.3%

Q2 2021

Best reaction

-8.6%

Q2 2016

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2025+0.0%+0.0%+0.0%
Q2 2024+7.5%+0.0%+0.0%
Q4 2023+7.2%+0.0%+0.0%
Q2 2023+1.1%+0.0%+0.0%
Q4 2022-2.1%+0.0%+420.0%
Q3 2022-2.5%+0.0%+0.0%
Q2 2022+8.0%+0.0%+0.0%
Q1 2022+0.9%+0.0%-75.0%
Q4 2021+0.7%+0.0%+66.7%
Q3 2021+5.8%+0.0%+503.7%
Q2 2021+23.3%+0.0%+4900.0%
Q4 2020-6.8%+0.0%+0.0%
Q2 2020+2.4%+0.0%+0.0%
Q4 2019+4.0%-20.0%-80.0%
Q2 2019+12.5%+0.0%+0.0%
Q4 2018-3.0%+0.0%+0.0%
Q2 2018+5.2%+0.0%+0.0%
Q4 2017+0.0%+0.0%+0.0%
Q2 2017+5.6%+0.0%+0.0%
Q4 2016+7.3%+0.0%+0.0%
Q2 2016-8.6%
Q4 2015+1.9%
Q2 2015+4.2%
Q4 2014-0.9%
Q2 2014-2.0%
Q4 2013+5.8%
Q3 2013+4.4%
Q2 2013+9.3%
Q4 2012-0.3%
Q3 2012+0.3%
Q2 2012+1.3%
Q4 2011+17.2%
Q2 2010+12.0%
Q4 2010+0.0%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro